References
Original article
Aggarwal, R. et al. PRESTO: a phase III, open-label study of intensification of androgen blockade in patients with high-risk biochemically relapsed castration-sensitive prostate cancer (AFT-19). J. Clin. Oncol. https://doi.org/10.1200/JCO.23.01157 (2024)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masone, M.C. ADT intensification to treat biochemically recurrent prostate cancer. Nat Rev Urol 21, 126 (2024). https://doi.org/10.1038/s41585-024-00862-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-024-00862-2
- Springer Nature Limited